Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
Authors
Hao Su (ORCID: https://orcid.org/0000-0002-7621-8730)
National Health Commission of the People's Republic of China
Cancer Foundation of China
National Key Research and Development Program of China
Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
Hao Su, Zhuang Jing, Xinxiang Li, Changlong Zhuang et al.
Citations
2 citations
Journal
BMC Medicine
Topics
Intraperitoneal and Appendiceal Malignancies
Field-Weighted Citation Impact (FWCI)
4.01
article
Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
Hao Su, Zhuang Jing, Xinxiang Li, Changlong Zhuang, Xishan Wang, Wang Ju, Wenbin Zhang, Jiansi Chen, Zhigang Jie, Wei Pei, Guoxin Li, Meijin Huang, Yunfeng Li, Guiying Wang, Zhimin Liu, Ming Liu, Haitao Zhou, Zejun Wang, Xuejun Sun, Ming Xie, Yanke Li, Qian Jiang, Dong-zhu Zeng, Xiangfu Zeng, Xinghong Zhang, Rui Zhang, Kang Wang
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 23(1)
Institutions
Hebei Medical University (CN), Nanchang University (CN), Guiyang Medical University (CN), Army Medical University (CN), Xinjiang Medical University (CN), Harbin Medical University (CN), Sun Yat-sen University (CN), Guangxi Medical University (CN), Zunyi Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), First Affiliated Hospital of Xinjiang Medical University (CN), Second People's Hospital of Yunnan Province (CN), Fudan University Shanghai Cancer Center (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Peking University Cancer Hospital (CN), Guizhou Cancer Hospital (CN), Fourth Hospital of Hebei Medical University (CN), Affiliated Hospital of Guizhou Medical University (CN), Third People 's Hospital of Chongqing (CN), Fourth Affiliated Hospital of Harbin Medical University (CN), Jiangsu Cancer Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), First Affiliated Hospital of Gannan Medical University (CN), Heilongjiang Academy of Land Reclamation Sciences (CN), First Hospital of China Medical University (CN), Henan Cancer Hospital (CN), Central Hospital of Zibo (CN), Tumor Hospital of Guangxi Medical University (CN), Liaoning Cancer Hospital & Institute (CN), First Affiliated Hospital of Nanchang University (CN), Hainan Medical University (CN), Chongqing Medical University (CN), China Medical University (CN)
Funders
Chinese Academy of Medical Sciences, National Health Commission of the People's Republic of China, Cancer Foundation of China, National Key Research and Development Program of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine